Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs SPYG✓SelectedUSD · SPYGGSK vs SPYG performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs SPYG

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+44.4%
SPYG return
+67.3%
Excess return
-22.9%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioSPYGExcessAlpha
1D+0.5%-0.9%+1.4%+0.7%
7D+1.1%+2.3%-1.2%+0.8%
30D+6.3%-6.5%+12.8%+7.4%
3M+1.8%-6.8%+8.7%+2.8%
6M+1.7%-3.1%+4.8%+1.9%
YTD+6.5%+8.0%-1.5%+4.4%
1Y+9.5%+10.2%-0.7%+6.9%
3Y+65.3%+91.0%-25.7%+41.0%
All+44.4%+67.3%-22.9%+23.3%

Cumulative growth

Daily Returns

Daily percentage return beside SPYG.

Daily Out/Under-Performance

Portfolio return minus SPYG return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × SPYG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded SPYG wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling